<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MINERAL OIL</span><br/><span class="topboxtradename">Agoral Plain, </span><span class="topboxtradename">Heavy Mineral Oil, </span><span class="topboxtradename">Kondremul Plain, </span><span class="topboxtradename">Milkinol, </span><span class="topboxtradename">Neo-Cultol, </span><span class="topboxtradename">Zymenol<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">stool softener</span><br/><b>Prototype: </b>Docusate<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>Liquid and emulsion</p>
<h1><a name="action">Actions</a></h1>
<p>Mixture of hydrocarbons obtained from petroleum. Aids passage of stool by lubricating it and by slowing the rate of water
         absorption from the feces while it is in the large intestine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Lubricates and softens feces, retards water absorption from fecal content, eases passage of stool.</p>
<h1><a name="uses">Uses</a></h1>
<p>Temporary relief of constipation, when straining at stool is contraindicated (e.g., hypertension, certain cardiac disorders,
         following anorectal surgery), and to relieve fecal impaction. Also used as pharmaceutical solvent and vehicle.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Nausea, vomiting, abdominal pain, intestinal obstruction; oral administration to dysphagic patients; use with emollients.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Oral use in older adult or debilitated patients; pregnancy (category C), lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Constipation</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1530 mL prn <span class="rdroute">PR</span> 90120 mL<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <img src="../images/special/greaterorequal.gif"/><i>6 y,</i> 515 mL once/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give preferably in the evening. Digestion and passage of food from stomach may be delayed if taken within 2 h of mealtime.</li>
<li>Give with patient in upright position and avoid giving just before patient retires. Potential of lipid pneumonia from aspiration
            is especially high in older adult and debilitated patients.
         </li>
<li>Use as retention enema is generally followed by a cleansing enema in 3060 min. Consult physician.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Pruritus ani; interference with postoperative anorectal wound healing. <span class="typehead">Respiratory:</span>
<span class="speceff-life">With aspiration: pulmonary granuloma, lipid pneumonitis</span>. <span class="typehead">GI:</span> Anorexia, nausea, vomiting. <span class="typehead"> Metabolic:</span> Nutritional deficiencies (with prolonged use). <span class="typehead">Hematologic:</span> Hypoprothrombinemia (with prolonged use). 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May potentiate effects of <span class="classification">oral anticoagulants</span> by decreasing the absorption of <b>Vitamin K;</b> large doses may decrease the absorption of <b>warfarin;</b>
<span class="classification">stool softeners</span> may form a concretion in the GI tract. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Limited absorption from GI tract. <span class="typehead">Distribution:</span> Distributes to mesenteric lymph nodes, intestinal mucosa, liver, and spleen. <span class="typehead"> Elimination:</span> Eliminated in stool in 610 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor bowel movements.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Be aware that prolonged use (&gt;2 wk) can reduce absorption of fat-soluble vitamins A, D, E, and K, carotene, calcium, and phosphates.</li>
<li>Frequent or prolonged use of mineral oil may result in dependence.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>